Your session is about to expire
← Back to Search
L-Serine Safety for ALS
Study Summary
This trial will test the safety of L-Serine in people with ALS. Different doses will be given to see what is safe.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My lung capacity is below 60% of the expected.I am between 18 and 85 years old.I am younger than 18 or older than 85.I have had a motor neuron disease for more than 3 years.I am either male or female.My ALS functional rating score is above 25.You have been diagnosed with ALS based on specific criteria.
- Group 1: 2.5 grams BID
- Group 2: .5 grams BID
- Group 3: 7.5 grams BID
- Group 4: 15 grams BID
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies within this research protocol available for participants?
"Clinicaltrials.gov reports that this particular medical trial, which was initially posted on 1st January 2013 and last amended on 28th July 2015 is not currently enrolling patients. However, there are 146 other studies actively recruiting at the moment."
Are applicants under the age of forty welcome to enroll in this clinical experiment?
"The prerequisite of this trial necessitates that potential participants be between 18 and 85 years old."
Can I become a participant in this clinical investigation?
"This trial is seeking 20 participants with amyotrophic lateral sclerosis to join. To be eligible, candidates must range between 18 and 85 years of age."
What is the approximate number of individuals taking part in this experiment?
"At this moment, the trial is not taking on patients. It was first posted on January 1st 2013 and last updated July 28th 2015. If you are searching for other options, there are currently 142 clinical trials recruiting participants with amyotrophic lateral sclerosis and 4 studies actively seeking people to take 15 grams BID (twice daily)."
To what maladies is a 15 gram twice-daily dosage typically prescribed?
"Iron insufficiency, amino acid deficiency disorder, and other related medical conditions can be remedied with 15 grams of the substance taken twice daily."
What other empirical research has been conducted involving a 15-gram twice daily administration?
"Initially studied in 2013 at Phoenix Neurological Associates, 15 grams BID has been the focus of 16 separate clinical trials. At present, four distinct studies are still recruiting patients; three taking place in San Francisco and one elsewhere."
Share this study with friends
Copy Link
Messenger